There is indeed a patent application, but it has not been authorized. Application number: 01134376.1 Application date: 2001.11.02 Name: Drug disclosure (announcement) number: CN1349822 Disclosure (announcement) date: 2002.05.22 Main classification number: A61K35/78 Divisional original application number: Classification number: A61K35 /78;A61P29/00;A61P19/02 Date of issuance: Priority: Applicant (patent right): Wang Jiakun Address: 653106 Inventor (designer) of the Second Village, Dongshan Village Committee, Yanhe Town, Hongta District, Yuxi City, Yunnan Province : Wang Jiakun; Wang Xiaogui International application: International publication: Date of entry into the country: Patent agency: Yunnan Province Qujing Patent Office Agent: Jiang Minghua Abstract The present invention relates to a drug for the treatment of rheumatoid and rheumatoid arthritis, consisting of Composed of Nux Vomica, Purple Gold Bark, San San San, Purple Golden Dragon and Mountain Begonia, this medicine dispels wind and removes dampness, has strong analgesic power, significant swelling effect, low cost, easy to take, small dosage, few contraindications for taking medicine, and each course of treatment In 10 days, mild patients are cured in 1-3 courses of treatment, and severe patients are cured in 4-5 courses. The effective rate in the treatment of rheumatoid and rheumatism is over 99.5% and the cure rate is over 96.0%. It is also effective in treating bone hyperplasia, Sciatic nerve, malignant tumors, mastitis, tracheitis, emphysema and other diseases all have significant therapeutic effectiveness and a cure rate of over 96.0%. This drug is safe, reliable and has no toxic or side effects.